Enhanced DNA repair and resistance to cisplatin in human ovarian cancer
- 1 December 1988
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 37 (24), 4597-4600
- https://doi.org/10.1016/0006-2952(88)90325-5
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patientInternational Journal of Cancer, 1987
- Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.JCI Insight, 1986
- Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletionBiochemical Pharmacology, 1985
- The significance of DNA cross-linking to cis-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cellsChemico-Biological Interactions, 1982
- Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-αNature, 1978
- Increased sensitivity of UV-repair-deficient human cells to DNA bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from Micrococcus luteusMutation Research, 1978
- A sensitive method to measure physical and chemical carcinogen-induced “unscheduled DNA synthesis” in rapidly dividing eukaryotic cellsExperimental Cell Research, 1974
- Effect of cis -Platinum(II)Diamminodichloride on Wild Type and Deoxyribonucleic Acid Repair-Deficient Mutants of Escherichia coliJournal of Bacteriology, 1973